← All companies
SPRB
Spruce Biosciences, Inc.
$43.14
-0.23 -0.53%
Key statistics
from XBRL data in SEC filingsMarket cap
$119M
Revenue (TTM)
$0.00
Net income (TTM)
-$37.2M
EPS (TTM)
$-35.82
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
$54.1M
Total assets
$56.2M
Gross margin
—
52-week range
$7.00 – $240.00
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change
Jul 27, 2026
8-K
Shareholder vote results
May 26, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Results of operations (earnings release)
May 13, 2026
8-K
Entered a material agreement; Other events
Apr 22, 2026
8-K
Terminated a material agreement
Mar 20, 2026
8-K
Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Director or officer change
Mar 9, 2026
10-K
Fiscal year ended 2025-12-31
Mar 9, 2026
8-K
Regulation FD disclosure; Other events
Feb 5, 2026
8-K
Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure
Jan 8, 2026
8-K
Director or officer change
Dec 15, 2025
8-K
Director or officer change
Dec 12, 2025
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
8-K
Director or officer change
Oct 17, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Other events
Oct 8, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K
Modified rights of security holders; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure
Jul 24, 2025
8-K
Delisting notice or listing-rule failure; Other events
Jun 12, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Item 5.08; Other events
May 29, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
May 6, 2025
8-K
Exit or disposal costs; Delisting notice or listing-rule failure
Apr 25, 2025
10-K
Fiscal year ended 2024-12-31
Apr 15, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 15, 2025
8-K
Results of operations (earnings release)
Apr 1, 2025
8-K
Director or officer change
Dec 27, 2024
8-K
Other events
Dec 10, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Results of operations (earnings release)
Nov 12, 2024
8-K
Delisting notice or listing-rule failure
Oct 28, 2024
10-Q
Quarter ended 2024-06-30
Aug 12, 2024
8-K
Results of operations (earnings release)
Aug 12, 2024
8-K
Entered a material agreement; Other events
Jun 18, 2024
8-K
Other events
Jun 3, 2024
8-K
Shareholder vote results
May 24, 2024
10-Q
Quarter ended 2024-03-31
May 13, 2024
8-K
Results of operations (earnings release)
May 13, 2024
8-K
Delisting notice or listing-rule failure
Apr 30, 2024